NASDAQ: DRMA
Dermata Therapeutics Inc Stock Ownership - Who owns Dermata Therapeutics?

Insider buying vs selling

Have Dermata Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when DRMA insiders and whales buy or sell their stock.

DRMA Shareholders

What type of owners hold Dermata Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Proehl Investment Ventures LLC45.55%2,905,544$2.09MInsider
Gerald T. Proehl12.55%800,610$576.44kInsider
Armistice Capital LLC6.44%411,000$295.92kInstitution
David F. Hale5.46%348,298$250.77kInsider
Mary Fisher3.09%196,946$141.80kInsider
Munera Maria E. Bedoyatoro1.80%114,630$82.53kInsider
Hoose Kyri K. Van1.23%78,741$56.69kInsider
Ubs Group Ag1.10%70,290$50.61kInstitution
Wendell Wierenga0.98%62,398$44.93kInsider
Kathleen D. Scott0.46%29,584$21.30kInsider

1 of 3

DRMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DRMA8.13%72.53%
THAR1.42%98.58%Net BuyingNet Buying
GLTO2.09%97.91%Net SellingNet Selling
CNSP0.74%20.81%
CMND11.72%0.00%

Dermata Therapeutics Stock Ownership FAQ

Who owns Dermata Therapeutics?

Dermata Therapeutics (NASDAQ: DRMA) is owned by 8.13% institutional shareholders, 72.53% Dermata Therapeutics insiders, and 19.34% retail investors. Proehl Investment Ventures LLC is the largest individual Dermata Therapeutics shareholder, owning 2.91M shares representing 45.55% of the company. Proehl Investment Ventures LLC's Dermata Therapeutics shares are currently valued at $2.06M.

If you're new to stock investing, here's how to buy Dermata Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.